StockData
Candel Therapeutics, Inc. logo

Candel Therapeutics, Inc. (CADL) stock

CADLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$5.32−0.08 (-1.48%)

Close on Nov 18, 2026Market cap $407.08MP/E –Yield –

Candel Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Candel Therapeutics's market cap was $701.81M on Nov 11, 2026, against $261.85M a year earlier. Over the last 5 years it ranged from $26.00M to $994.87M, with a median of $181.95M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$701.81M+126.3%
2025Dec 31, 2025$310.16M+11.2%
2024Dec 31, 2024$278.85M+555.9%
2023Dec 29, 2023$42.51M-17.8%
2022Dec 30, 2022$51.72M-76.9%
2021Dec 31, 2021$224.35M–

More Candel Therapeutics figures

See a number that looks wrong?